vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and ServisFirst Bancshares, Inc. (SFBS). Click either name above to swap in a different company.
ServisFirst Bancshares, Inc. is the larger business by last-quarter revenue ($159.0M vs $83.5M, roughly 1.9× BillionToOne, Inc.). ServisFirst Bancshares, Inc. runs the higher net margin — 52.2% vs 6.8%, a 45.3% gap on every dollar of revenue.
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
ServisFirst Bancshares, Inc. is a U.S.-based bank holding company operating full-service banking locations primarily across the Southeastern United States. It offers a full suite of commercial banking, consumer banking, wealth management, and mortgage lending services to small and medium-sized businesses, professional clients, and individual consumers.
BLLN vs SFBS — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $159.0M |
| Net Profit | $5.7M | $83.0M |
| Gross Margin | 69.9% | — |
| Operating Margin | 11.5% | — |
| Net Margin | 6.8% | 52.2% |
| Revenue YoY | 117.4% | — |
| Net Profit YoY | 138.3% | 31.2% |
| EPS (diluted) | $0.10 | $1.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $159.0M | ||
| Q4 25 | — | $162.2M | ||
| Q3 25 | $83.5M | $136.3M | ||
| Q2 25 | — | $132.1M | ||
| Q1 25 | — | $131.8M | ||
| Q4 24 | — | $131.9M | ||
| Q3 24 | $38.4M | $123.7M | ||
| Q2 24 | — | $114.8M |
| Q1 26 | — | $83.0M | ||
| Q4 25 | — | $86.4M | ||
| Q3 25 | $5.7M | $65.6M | ||
| Q2 25 | — | $61.4M | ||
| Q1 25 | — | $63.2M | ||
| Q4 24 | — | $65.2M | ||
| Q3 24 | $-14.9M | $59.9M | ||
| Q2 24 | — | $52.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 69.9% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 52.6% | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 66.3% | ||
| Q3 25 | 11.5% | 57.8% | ||
| Q2 25 | — | 58.0% | ||
| Q1 25 | — | 60.0% | ||
| Q4 24 | — | 60.2% | ||
| Q3 24 | -32.9% | 58.5% | ||
| Q2 24 | — | 58.0% |
| Q1 26 | — | 52.2% | ||
| Q4 25 | — | 59.0% | ||
| Q3 25 | 6.8% | 48.1% | ||
| Q2 25 | — | 46.5% | ||
| Q1 25 | — | 48.0% | ||
| Q4 24 | — | 52.9% | ||
| Q3 24 | -38.8% | 48.4% | ||
| Q2 24 | — | 45.4% |
| Q1 26 | — | $1.52 | ||
| Q4 25 | — | $1.58 | ||
| Q3 25 | $0.10 | $1.20 | ||
| Q2 25 | — | $1.12 | ||
| Q1 25 | — | $1.16 | ||
| Q4 24 | — | $1.19 | ||
| Q3 24 | $-1.47 | $1.10 | ||
| Q2 24 | — | $0.95 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $1.8B |
| Total DebtLower is stronger | $55.0M | — |
| Stockholders' EquityBook value | $-239.5M | $1.9B |
| Total Assets | $327.5M | $18.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $1.8B | ||
| Q4 25 | — | — | ||
| Q3 25 | $195.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $55.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $1.9B | ||
| Q4 25 | — | $1.8B | ||
| Q3 25 | $-239.5M | $1.8B | ||
| Q2 25 | — | $1.7B | ||
| Q1 25 | — | $1.7B | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | $-242.9M | $1.6B | ||
| Q2 24 | — | $1.5B |
| Q1 26 | — | $18.2B | ||
| Q4 25 | — | $17.7B | ||
| Q3 25 | $327.5M | $17.6B | ||
| Q2 25 | — | $17.4B | ||
| Q1 25 | — | $18.6B | ||
| Q4 24 | — | $17.4B | ||
| Q3 24 | — | $16.4B | ||
| Q2 24 | — | $16.0B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | — |
| Free Cash FlowOCF − Capex | $6.5M | — |
| FCF MarginFCF / Revenue | 7.7% | — |
| Capex IntensityCapex / Revenue | 8.8% | — |
| Cash ConversionOCF / Net Profit | 2.42× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $355.2M | ||
| Q3 25 | $13.8M | $140.9M | ||
| Q2 25 | — | $67.6M | ||
| Q1 25 | — | $48.0M | ||
| Q4 24 | — | $252.9M | ||
| Q3 24 | — | $84.0M | ||
| Q2 24 | — | $48.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $6.5M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 7.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 8.8% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.11× | ||
| Q3 25 | 2.42× | 2.15× | ||
| Q2 25 | — | 1.10× | ||
| Q1 25 | — | 0.76× | ||
| Q4 24 | — | 3.88× | ||
| Q3 24 | — | 1.40× | ||
| Q2 24 | — | 0.93× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
SFBS
| Net Interest Income | $148.1M | 93% |
| Noninterest Income | $10.8M | 7% |
